Thursday, February 12
LYSOGENE has been invited to give a platform presentation “AAVrh10-SGSH intracerebral gene therapy corrects the defect and improves the health status in MPS type IIIA” at the 11th annual WORLD Symposium on February 12th at the Hyatt Regency, Orlando, Florida, USA.
The WorldSymposium brought together over 1000 advocates, clinicians, scientists, and industry leaders involved in advancing our understanding and treatment of lysosomal diseases.
A key component of the conference was the data presented in either oral or poster form, but many also attended for the great line-up of speakers, including a keynote address from former and current National Institutes of Health (NIH) and US Food and Drug Administration (FDA) executives.
For more information you can consult the internet site of the symposium: